Search - tctmd.com

Displaying 141 - 160 of 294

Sort: Relevancy | Date

ILLUMENATE EU: No Higher Paclitaxel-Related Deaths as Talk Turns to Patency

News Daily News

ILLUMENATE EU: No Higher Paclitaxel-Related Deaths as Talk Turns to Patency

July 02, 2020

Carotid Endarterectomy Little Help in Asymptomatic Patients: VA Study

News Daily News

Carotid Endarterectomy Little Help in Asymptomatic Patients: VA Study

June 04, 2020

New Questions About Triple Therapy After PAD Revascularization: VOYAGER PAD Substudy

News Conference News ACC 2020

New Questions About Triple Therapy After PAD Revascularization: VOYAGER PAD Substudy

April 02, 2020

VOYAGER PAD Efficacy and Safety of Rivaroxaban in Patients with Symptomatic PAD undergoing Revascularization with and without Clopidogrel

Presentation ACC 2020

VOYAGER PAD Efficacy and Safety of Rivaroxaban in Patients with Symptomatic PAD undergoing Revascularization with and without Clopidogrel

Presenter: William Hiatt

March 29, 2020

VOYAGER PAD: Rivaroxaban Bests Aspirin Alone for Preventing Limb and CV Events

News Conference News ACC 2020

VOYAGER PAD: Rivaroxaban Bests Aspirin Alone for Preventing Limb and CV Events

March 28, 2020

A ‘Virtual’ ACC 2020? TCTMD Has You Covered, However Things Roll Out

News Opinion Editor's Corner

A ‘Virtual’ ACC 2020? TCTMD Has You Covered, However Things Roll Out

March 16, 2020

Veterans Study Shows Areas of Need for CLI Care

News Daily News

Veterans Study Shows Areas of Need for CLI Care

February 17, 2020

Outcome Differences Between Men and Women With PAD: EUCLID Insights

News Daily News

Outcome Differences Between Men and Women With PAD: EUCLID Insights

February 11, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2020

January 31, 2020

Venous Stents: Long-term Follow-up Plus a New Contender

News Conference News ISET 2020

Venous Stents: Long-term Follow-up Plus a New Contender

January 24, 2020

TCAR’s Rise Is Shaking Up Carotid Stenosis, but Dependable Data Lag Behind

News Features

TCAR’s Rise Is Shaking Up Carotid Stenosis, but Dependable Data Lag Behind

January 02, 2020

Carotid Stenting Makes a Strong Showing in the CREST-2 Registry

News Daily News

Carotid Stenting Makes a Strong Showing in the CREST-2 Registry

December 23, 2019

Year in Review: Endovascular Saw Paclitaxel Storm Rage, CLI Care Advance in 2019

News Features

Year in Review: Endovascular Saw Paclitaxel Storm Rage, CLI Care Advance in 2019

December 12, 2019

Could Revascularization of Carotid Stenosis Reverse Cognitive Deficits?

News Conference News VEITH 2019

Could Revascularization of Carotid Stenosis Reverse Cognitive Deficits?

November 25, 2019

Lower Cholesterol Cuts CV Events: Treat Stroke to Target Trial

News Conference News AHA 2019

Lower Cholesterol Cuts CV Events: Treat Stroke to Target Trial

November 18, 2019

Bleeding Risk Similar for Peripheral, Coronary Revascularization: EUCLID

News Daily News

Bleeding Risk Similar for Peripheral, Coronary Revascularization: EUCLID

October 16, 2019

News Daily News

German Analysis Supports Long-term Safety of Paclitaxel-Based Therapies

October 09, 2019

LEVANT: Patient-Level Data Show No Increase in 5-Year Death for Paclitaxel DCBs in PAD

News Conference News TCT 2019

LEVANT: Patient-Level Data Show No Increase in 5-Year Death for Paclitaxel DCBs in PAD

September 28, 2019

Long-Term Safety of Drug-Coated Devices for Femoropopliteal Artery Revascularization: Updated Analysis of Medicare Beneficiary Data

Presentation TCT 2019

Long-Term Safety of Drug-Coated Devices for Femoropopliteal Artery Revascularization: Updated Analysis of Medicare Beneficiary Data

Presenter: Eric Secemsky

September 27, 2019

Complex CLI Case Review 3: What Is Possible in the OBL?

Presentation TCT 2019

Complex CLI Case Review 3: What Is Possible in the OBL?

Presenter: Eric Dippel

September 25, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.